Tag: Aspirin
Preventive Aspirin Should Be Based on Benefit, Not Age
Authors urge primary care physicians to make case-by-case basis decisions based on benefit-to-risk
Aspirin Use Tied to Incident Heart Failure in At-Risk Adults
Aspirin use associated with increased risk for incident heart failure among individuals with or without a history of cardiovascular disease
USPSTF Recommends Aspirin for Those at High Risk for Preeclampsia
Low-dose aspirin has substantial benefit for reducing risk for preeclampsia, preterm birth, IUGR, perinatal mortality
Fixed-Dose Combination Therapies Reduce Cardiovascular Risk
Fixed-dose combo with BP-lowering meds, statin, and aspirin yields largest reduction in cardiovascular risk
Preventive Aspirin Use Up for Seniors With Versus Without Diabetes
Among those with diabetes, likelihood of using aspirin did not differ for older versus younger (60 to 69 years) age categories
ACC: 81-mg, 325-mg Aspirin Similarly Effective in ASCVD
Patients assigned to 325-mg aspirin had higher incidence of dose switching, fewer median days of exposure to assigned dose
Adding Aspirin May Up Risk for Patients on DOAC for A-Fib/VTE
Among patients with a-fib and/or VTE, about one-third received ASA in addition to a DOAC with no clear indication for ASA
Aspirin Use Tied to Lower Rates of COVID-19 Infection
Adults using low-dose aspirin for primary or secondary prevention of CVD had lower likelihood of COVID-19 infection versus nonusers
USPSTF Recommends Low-Dose Aspirin to Prevent Preeclampsia
Substantial net benefit observed for daily low-dose aspirin use in pregnant women at high risk for preeclampsia
Aspirin Overused, Statins Underused for CVD Prevention in Seniors
56.4 percent aged 75 years and older using statin for secondary cardiovascular event prevention; 45.3 percent taking aspirin for primary prevention
